Kolexia
Sloma Ivan Pharmacien
Sloma Ivan
Pharmacien
Hôpital Henri Mondor
Créteil, France
72 Activités
327 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie myéloïde chronique BCR-ABL positive Leucémie myéloïde Leucémie myélomonocytaire chronique Syndromes myélodysplasiques Lymphomes Crise blastique Éosinophilie Drépanocytose

Collaborateurs

Voir plus
Turhan Ali
Turhan Ali
Cabinet libéral, Neuilly-sur-Seine, France
Wagner-Ballon Orianne
Wagner-Ballon Orianne
Hôpital Henri Mondor, Créteil, France
Bennaceur-Griscelli Annelise
Bennaceur-Griscelli Annelise
Hôpital Paul Brousse, Villejuif, France
Maury Sebastien
Maury Sebastien
Hôpital Henri Mondor, Créteil, France

Industries

Voir plus
Novartis
8 collaboration(s)
Dernière en 2023
Incyte
4 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Long-term outcome after autologous BCR::ABL1-negative peripheral blood stem cell transplantation in adults with Philadelphia-positive acute lymphoblastic leukemia: a comparative study.
Haematologica   30 novembre 2023
Laboratories Can Reliably Detect Clinically Relevant Variants in the TP53 Gene below 10 % Allelic Frequency: A Multicenter Study of ERIC, the European Research Initiative on CLL
65th ASH Annual Meeting Abstracts   02 novembre 2023
Mutation of Epigenetic Regulators at Diagnosis Is an Independent Predictor of Tyrosine Kinase Inhibitor Treatment Failure: A Report from the Residiag Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
mutational status affects myelodysplastic syndrome evolution to chronic myelomonocytic leukemia.
Haematologica   01 novembre 2023
CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HELPER T-CELL LYMPHOMA: AN ANCILLARY STUDY OF THE ORACLE TRIAL, A LYSA STUDY
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: TET2 MUTATIONAL STATUS AFFECTS MYELODYSPLASTIC SYNDROME EVOLUTION TO CHRONIC MYELOMONOCYTIC LEUKEMIA
The 17th International Congress on Myelodysplastic Syndromes   01 mai 2023
Effective use of intensive treatment against multiple myeloma of recipient origin after allogeneic transplantation for acute myeloid leukemia.
Leukemia research reports   16 mars 2023
ABO blood barrier to engraftment after allogeneic stem cell transplantation in sickle cell disease: A case-story with two successive HLA-matched sibling donors.
American journal of hematology   27 décembre 2022
Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission.
Haematologica   01 décembre 2022
Evaluation of two new highly multiplexed PCR assays as an alternative to next-generation sequencing for IDH1/2 mutation detection.
Molecular oncology   17 octobre 2022